chr1-50419056-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032110.3(DMRTA2):c.1238C>T(p.Pro413Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000176 in 1,305,178 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032110.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DMRTA2 | NM_032110.3 | c.1238C>T | p.Pro413Leu | missense_variant | 3/3 | ENST00000404795.4 | NP_115486.1 | |
DMRTA2 | XM_011541937.3 | c.1238C>T | p.Pro413Leu | missense_variant | 2/2 | XP_011540239.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMRTA2 | ENST00000404795.4 | c.1238C>T | p.Pro413Leu | missense_variant | 3/3 | 5 | NM_032110.3 | ENSP00000383909.3 | ||
DMRTA2 | ENST00000418121.5 | c.1238C>T | p.Pro413Leu | missense_variant | 2/2 | 1 | ENSP00000399370.1 |
Frequencies
GnomAD3 genomes AF: 0.00000666 AC: 1AN: 150206Hom.: 0 Cov.: 34
GnomAD4 exome AF: 0.0000190 AC: 22AN: 1154864Hom.: 1 Cov.: 29 AF XY: 0.0000214 AC XY: 12AN XY: 561140
GnomAD4 genome AF: 0.00000665 AC: 1AN: 150314Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 73360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2021 | The c.1238C>T (p.P413L) alteration is located in exon 3 (coding exon 2) of the DMRTA2 gene. This alteration results from a C to T substitution at nucleotide position 1238, causing the proline (P) at amino acid position 413 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at